TY - JOUR
T1 - Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment
T2 - study protocol
AU - Crable, Erika L.
AU - Grogan, Colleen M.
AU - Purtle, Jonathan
AU - Roesch, Scott C.
AU - Aarons, Gregory A.
N1 - Funding Information:
ELC would like to acknowledge the training she receives as a fellow in the Implementation Research Institute (IRI) at the Washington University in St. Louis Brown School, including individual mentorship from Dr. Mark McGovern and Dr. Emma Beth McGinty. ELC would also like to acknowledge the training and support she received as a fellow (now alumna) in the Lifespan/Brown University Criminal Justice Research Program on Substance Use and HIV.
Funding Information:
This study is funded by the National Institutes of Health, National Institute on Drug Abuse (K01 DA056838-01). ELC is a fellow, and JP and GAA are core faculty with the Implementation Research Institute (IRI, at the George Warren Brown School of Social Work, Washington University in St. Louis; through an award from the National Institute of Mental Health (R25 MH080916). ELC is also an alumnus of the Lifespan/Brown University Criminal Justice Research Program on Substance Use and HIV through an award from the National Institute on Drug Abuse (R25 DA037190).
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Background: Policy is a powerful tool for systematically altering healthcare access and quality, but the research to policy gap impedes translating evidence-based practices into public policy and limits widespread improvements in service and population health outcomes. The US opioid epidemic disproportionately impacts Medicaid members who rely on publicly funded benefits to access evidence-based treatment including medications for opioid use disorder (MOUD). A myriad of misaligned policies and evidence-use behaviors by policymakers across federal agencies, state Medicaid agencies, and managed care organizations limit coverage of and access to MOUD for Medicaid members. Dissemination strategies that improve policymakers’ use of current evidence are critical to improving MOUD benefits and reducing health disparities. However, no research describes key determinants of Medicaid policymakers’ evidence use behaviors or preferences, and few studies have examined data-driven approaches to developing dissemination strategies to enhance evidence-informed policymaking. This study aims to identify determinants and intermediaries that influence policymakers’ evidence use behaviors, then develop and test data-driven tailored dissemination strategies that promote MOUD coverage in benefit arrays. Methods: Guided by the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework, we will conduct a national survey of state Medicaid agency and managed care organization policymakers to identify determinants and intermediaries that influence how they seek, receive, and use research in their decision-making processes. We will use latent class methods to empirically identify subgroups of agencies with distinct evidence use behaviors. A 10-step dissemination strategy development and specification process will be used to tailor strategies to significant predictors identified for each latent class. Tailored dissemination strategies will be deployed to each class of policymakers and assessed for their acceptability, appropriateness, and feasibility for delivering evidence about MOUD benefit design. Discussion: This study will illuminate key determinants and intermediaries that influence policymakers’ evidence use behaviors when designing benefits for MOUD. This study will produce a critically needed set of data-driven, tailored policy dissemination strategies. Study results will inform a subsequent multi-site trial measuring the effectiveness of tailored dissemination strategies on MOUD benefit design and implementation. Lessons from dissemination strategy development will inform future research about policymakers’ evidence use preferences and offer a replicable process for tailoring dissemination strategies.
AB - Background: Policy is a powerful tool for systematically altering healthcare access and quality, but the research to policy gap impedes translating evidence-based practices into public policy and limits widespread improvements in service and population health outcomes. The US opioid epidemic disproportionately impacts Medicaid members who rely on publicly funded benefits to access evidence-based treatment including medications for opioid use disorder (MOUD). A myriad of misaligned policies and evidence-use behaviors by policymakers across federal agencies, state Medicaid agencies, and managed care organizations limit coverage of and access to MOUD for Medicaid members. Dissemination strategies that improve policymakers’ use of current evidence are critical to improving MOUD benefits and reducing health disparities. However, no research describes key determinants of Medicaid policymakers’ evidence use behaviors or preferences, and few studies have examined data-driven approaches to developing dissemination strategies to enhance evidence-informed policymaking. This study aims to identify determinants and intermediaries that influence policymakers’ evidence use behaviors, then develop and test data-driven tailored dissemination strategies that promote MOUD coverage in benefit arrays. Methods: Guided by the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework, we will conduct a national survey of state Medicaid agency and managed care organization policymakers to identify determinants and intermediaries that influence how they seek, receive, and use research in their decision-making processes. We will use latent class methods to empirically identify subgroups of agencies with distinct evidence use behaviors. A 10-step dissemination strategy development and specification process will be used to tailor strategies to significant predictors identified for each latent class. Tailored dissemination strategies will be deployed to each class of policymakers and assessed for their acceptability, appropriateness, and feasibility for delivering evidence about MOUD benefit design. Discussion: This study will illuminate key determinants and intermediaries that influence policymakers’ evidence use behaviors when designing benefits for MOUD. This study will produce a critically needed set of data-driven, tailored policy dissemination strategies. Study results will inform a subsequent multi-site trial measuring the effectiveness of tailored dissemination strategies on MOUD benefit design and implementation. Lessons from dissemination strategy development will inform future research about policymakers’ evidence use preferences and offer a replicable process for tailoring dissemination strategies.
KW - Dissemination strategies
KW - EPIS framework
KW - Information dissemination
KW - Managed care populations
KW - Medicaid
KW - Opioid-related disorders
KW - Policy
KW - Politics
KW - Prior authorization
KW - Substance use disorder treatment
UR - http://www.scopus.com/inward/record.url?scp=85159882433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159882433&partnerID=8YFLogxK
U2 - 10.1186/s43058-023-00396-5
DO - 10.1186/s43058-023-00396-5
M3 - Article
AN - SCOPUS:85159882433
SN - 2662-2211
VL - 4
JO - Implementation science communications
JF - Implementation science communications
IS - 1
M1 - 16
ER -